Pfizer Reports Promising Results In First Phase Of Vaccine Trial | NBC Nightly News
- Update Date：
- Post Date：
The trial gave 24 of its 45 participants two doses of the coronavirus vaccine, and all 24 produced antibodies. The vaccine will undergo two more trials before possible approval, which Pfizer hopes to get by the end of the year. » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Watch more NBC video: http://bit.ly/MoreNBCNews NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments […]